Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole in NERD or Erosive GERD
NCT00163306Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of pantoprazole in gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), sponsored by Takeda. Started May 2005; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT00163306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163306.